Jerusalem Pharmaceuticals Co. Ltd. (PEX:JPH)

Jerusalem Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	14.05	11.74	6.59	7.73	5.44	1.96
Short-Term Investments	-	0.09	0.05	0.03	0.03	0.04
Trading Asset Securities	-	-	-	0.03	0.03	0.02
Cash & Short-Term Investments	14.05	11.84	6.64	7.79	5.49	2.02
Cash Growth	67.49%	78.27%	-14.72%	41.69%	171.63%	67.77%
Accounts Receivable	25.92	28.25	29.95	31.63	30.81	24.2
Other Receivables	0.09	-	0	-	-	0.72
Receivables	26.01	28.25	29.95	31.63	30.81	24.92
Inventory	8.04	8.34	10.41	10.88	14.76	14.44
Prepaid Expenses	0.51	0.31	0.51	0.4	0.73	0.73
Other Current Assets	2.59	2.8	3.1	2.22	3.33	3.2
Total Current Assets	51.21	51.54	50.61	52.91	55.12	45.3
Property, Plant & Equipment	26.66	25.9	27.13	25.48	27.47	27.15
Long-Term Investments	8.71	7.24	6.42	3.22	0.7	1.22
Other Intangible Assets	1.88	1.8	1.55	1.52	3.04	3.53
Long-Term Deferred Tax Assets	0.42	0.4	0.28	0.27	0.2	0.16
Other Long-Term Assets	2.24	2.27	0.32	0.32	0.37	0.36
Total Assets	91.13	89.15	86.32	83.72	86.89	77.71
Accounts Payable	3.7	3.29	3.48	6.56	5.11	4.35
Accrued Expenses	2.85	3.58	2.33	1.32	1.99	1.39
Short-Term Debt	0.45	0.46	0.52	0.65	0.78	1.69
Current Portion of Long-Term Debt	-	0.61	1.13	0.69	0.57	0.6
Current Portion of Leases	0.13	0.3	0.48	0.36	0.55	0.64
Current Income Taxes Payable	1.7	1.29	2.42	2.67	1.66	0.18
Other Current Liabilities	2.87	2.46	1.95	1.46	2.3	2
Total Current Liabilities	11.71	12	12.32	13.7	12.97	10.84
Long-Term Debt	-	-	-	-	-	0.38
Long-Term Leases	0.2	0.14	0.33	0.49	0.72	0.55
Long-Term Unearned Revenue	0.48	0.29	-	-	-	-
Total Liabilities	17.55	17.55	17.44	18.49	18.32	16.07
Common Stock	18	18	18	18	18	18
Additional Paid-In Capital	3.72	3.72	3.72	3.72	3.72	3.72
Retained Earnings	44.94	42.83	39.6	34.9	29.89	24.73
Comprehensive Income & Other	5.91	6.04	6.52	7.65	14.87	12.87
Total Common Equity	72.57	70.6	67.84	64.27	66.47	59.32
Minority Interest	1.02	1.01	1.04	0.96	2.1	2.32
Shareholders' Equity	73.59	71.61	68.88	65.23	68.57	61.64
Total Liabilities & Equity	91.13	89.15	86.32	83.72	86.89	77.71
Total Debt	0.78	1.51	2.47	2.18	2.63	3.85
Net Cash (Debt)	13.26	10.32	4.17	5.6	2.86	-1.83
Net Cash Growth	131.13%	147.75%	-25.64%	95.69%	-	-
Net Cash Per Share	0.74	0.57	0.23	0.31	0.16	-0.10
Filing Date Shares Outstanding	18	18	18	18	18	18
Total Common Shares Outstanding	18	18	18	18	18	18
Working Capital	39.5	39.53	38.28	39.2	42.16	34.46
Book Value Per Share	4.03	3.92	3.77	3.57	3.69	3.30
Tangible Book Value	70.68	68.8	66.29	62.75	63.43	55.8
Tangible Book Value Per Share	3.93	3.82	3.68	3.49	3.52	3.10
Land	9.43	9.49	10.63	9.24	8.31	8.13
Buildings	15.36	15.42	15.64	15.73	16.34	15.87
Machinery	31.75	30.8	29.47	28.78	31.82	29.69

Updated Nov 14, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.